Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 7/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 3/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4951414 | 1.00 | NFE2L2 (0.50) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| Anisole SCHEMBL29005803 | 0.87 | TRPA1 (0.56) | NFE2L2TRPA1MEN1KMT2A | |
| SCHEMBL6737776 | 0.85 | NFE2L2 (0.56) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL14703725 | 0.85 | NFE2L2 (0.56) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL6737772 | 0.85 | NFE2L2 (0.56) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL30364986 | 0.85 | NFE2L2 (0.56) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL29054340 | 0.83 | NFE2L2 (0.45) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL29047693 | 0.80 | HSD11B1 (0.42) | NFE2L2MAOBMEN1KMT2AHSD11B1 | |
| SCHEMBL29627775 | 0.80 | NFE2L2 (0.47) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL29627779 | 0.80 | NFE2L2 (0.47) | NFE2L2TRPA1MAOBCYP19A1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111039920-B | Chiral tetraphenylethylene and synthesis method thereof | 山东大学 | 2021-01-12 | — | — | CN | claimed |
| CN-111039920-A | Chiral tetraphenylethylene and synthesis method thereof | 山东大学 | 2020-04-21 | — | — | CN | claimed |
| JP-7133284-A | — | — | None | — | — | JP | disclosed |
| EP-3527593-B1 | ISOCYANATE COMPOSITION, METHOD FOR PRODUCING ISOCYANATE COMPOSITION, AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-23 | — | — | EP | disclosed |
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-114957128-B | Diaryl imidazolium salt and antibacterial application thereof | 四川大学 | 2024-07-23 | — | — | CN | disclosed |
| CN-112979917-B | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | 旭化成株式会社 | 2023-04-25 | — | — | CN | disclosed |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-109790269-B | Isocyanate composition, method for producing isocyanate composition, and method for producing isocyanate polymer | 旭化成株式会社 | 2022-06-14 | — | — | CN | disclosed |
| CN-109803992-B | Isocyanate composition and method for producing isocyanate polymer | 旭化成株式会社 | 2022-05-24 | — | — | CN | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4568705-A | HIGH RESILIENT POLYETHER-AND ESTERURETHANES | BASF WYANDOTTE CORPORATION (US) | 1986-02-04 | — | — | US | disclosed |
| EP-0163188-A2 | A graft polymer dispersion in a mixture of low molecular weight polyols and polyether polyols and polyurethane foams prepared therefrom | BASF Corporation (US) | 1985-12-04 | — | — | EP | disclosed |
| US-4555527-A | POLYURETHANE FOAM | BASF WYANDOTTE CORPORATION (US) | 1985-11-26 | — | — | US | disclosed |
| US-4522976-A | Graft polymer dispersion in a mixture of low molecular weight polyols and polyether polyols and polyurethane foams prepared therefrom | BASF WYANDOTTE CORPORATION (US) | 1985-06-11 | — | — | US | disclosed |
| US-4503207-A | UNSATURATION-CONTAINING POLYOLS | BASF WYANDOTTE CORPORATION (US) | 1985-03-05 | — | — | US | disclosed |
| US-4458038-A | ADDITION-CONDENSATION COPOLYMERS | BASF WYANDOTTE CORPORATION (US) | 1984-07-03 | — | — | US | disclosed |
| US-4454255-A | 0.001 TO 0.09 MOLE OF INDUCED UNSATURATION PER MOLE OF POLYOL MIXTURE | BASF WYANDOTTE CORPORATION (US) | 1984-06-12 | — | — | US | disclosed |
| EP-0091036-A2 | Process for the preparation of white graft polymer dispersions and flame-retardant polyurethane foams | BASF Corporation (US) | 1983-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548975-B2 | Isocyanate composition and method for producing isocyanate polymer | IDH3A, IDH2, IDH3B | NFE2L2 1131/4885TRPA1 899/4885MAOB 2543/4885 |
| US-20230114799-A1 | ISOCYANATE COMPOSITION AND METHOD FOR PRODUCING ISOCYANATE POLYMER | IDH3A, IDH2, IDH3B | NFE2L2 1150/4885TRPA1 953/4885MAOB 2429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.